1 | 1320301 | Thrombomodulin is a cofactor for thrombin degradation of recombinant single-chain urokinase plasminogen activator "in vitro" and in a perfused rabbit heart model. | Thromb Haemost | 1992 Feb 3 |
1 |
2 | 1699514 | Systemic amiloride inhibits experimentally induced neovascularization. | Arch Ophthalmol | 1990 Oct |
1 |
3 | 1705427 | Interactions of saruplase with acetylsalicylic acid, heparin, glyceryl trinitrate, tranexamic acid and aprotinin in a rabbit pulmonary thrombosis model. | Arzneimittelforschung | 1990 Oct |
1 |
4 | 1778666 | Tear plasminogen activators--indicators of epithelial cell destruction. The effect of scraping, n-heptanol debridement, and alkali burn of the cornea on the plasminogen activator activity of rabbit tears. | Int Ophthalmol | 1991 Nov |
1 |
5 | 1909616 | Pathogenesis of corneal epithelial defects: role of plasminogen activator. | Curr Eye Res | 1991 May |
2 |
6 | 2052741 | Taprostene, a stable prostacyclin analogue, enhances the thrombolytic efficacy of saruplase (recombinant single-chain urokinase-type plasminogen activator) in rabbits with pulmonary embolized thrombi. | Prostaglandins | 1991 Jun |
1 |
7 | 2125971 | Thrombolytic effects of tissue-type and urokinase-type plasminogen activators in rabbits with experimental pulmonary thromboembolization. | Fukuoka Igaku Zasshi | 1990 Sep |
1 |
8 | 2128973 | Fibrin specific thrombolysis by two-chain urokinase-type plasminogen activator cleaved after arginine 156 by thrombin. | Thromb Haemost | 1990 Nov 30 |
1 |
9 | 2877508 | Effect of a selective thrombin inhibitor MCI-9038 on fibrinolysis in vitro and in vivo. | Thromb Haemost | 1986 Aug 20 |
2 |
10 | 6173346 | Plasminogen activator (urokinase) causes vascularization of the cornea. | Invest Ophthalmol Vis Sci | 1982 Feb |
1 |
11 | 7842213 | Effects of intrapleural heparin or urokinase on the extent of tetracycline-induced pleural disease. | Am J Respir Crit Care Med | 1995 Feb |
3 |
12 | 8344937 | Epithelial glycoprotein-330 mediates endocytosis of plasminogen activator-plasminogen activator inhibitor type-1 complexes. | J Biol Chem | 1993 Aug 5 |
2 |
13 | 8814143 | Platelet-activating factor enhances urokinase-type plasminogen activator gene expression in corneal epithelium. | Invest Ophthalmol Vis Sci | 1996 Sep |
7 |
14 | 9102830 | [Inhibition of angiogenesis in the cornea with amiloride]. | Srp Arh Celok Lek | 1996 May-Jun |
2 |
15 | 9684800 | Native atherosclerosis and vein graft arterialization: association with increased urokinase receptor expression in vitro and in vivo. | Thromb Haemost | 1998 Jul |
1 |
16 | 9759655 | Urokinase-dependent angiogenesis in vitro and diacylglycerol production are blocked by antisense oligonucleotides against the urokinase receptor. | Lab Invest | 1998 Sep |
4 |
17 | 10431800 | The appearance and possible role of plasminogen activator of urokinase type (u-PA) activity in the cornea related to soft contact lens wear in rabbits. | Doc Ophthalmol | 1998 |
2 |
18 | 10544394 | Topical amiloride accelerates healing and delays neovascularization in mechanically produced corneal ulcers in rabbits. | Methods Find Exp Clin Pharmacol | 1999 Sep |
1 |
19 | 12149463 | Increased expression of urokinase during atherosclerotic lesion development causes arterial constriction and lumen loss, and accelerates lesion growth. | Proc Natl Acad Sci U S A | 2002 Aug 6 |
1 |
20 | 12897821 | Ethyl isopropyl amiloride inhibits smooth muscle cell proliferation and migration by inducing apoptosis and antagonizing urokinase plasminogen activator activity. | Can J Physiol Pharmacol | 2003 Jul |
2 |
21 | 15866288 | Effects of inhibition of urokinase-type plasminogen activator (u-PA) by amiloride in the cornea and tear fluid of eyes irradiated with UVB. | Acta Histochem | 2005 |
6 |
22 | 16638992 | Promotion of corneal epithelial wound healing in vitro and in vivo by annexin A5. | Invest Ophthalmol Vis Sci | 2006 May |
1 |
23 | 19666776 | Regulation of intrapleural fibrinolysis by urokinase-alpha-macroglobulin complexes in tetracycline-induced pleural injury in rabbits. | Am J Physiol Lung Cell Mol Physiol | 2009 Oct |
4 |
24 | 25140386 | Targeting of plasminogen activator inhibitor 1 improves fibrinolytic therapy for tetracycline-induced pleural injury in rabbits. | Am J Respir Cell Mol Biol | 2015 Apr |
2 |